Background Over 200 schizophrenia risk loci have been identified by genome-wide
association studies (GWASs). However, the majority of risk loci were identified in …

Background: despite the fact that the genetic basis of schizophrenia has been intensively
studied for more than two decades, our contemporary knowledge in this field is rather …

Schizophrenia (SZ) is a prevalent functional psychosis characterized by clinical behavioural
symptoms and underlying abnormalities in brain function. Genome-wide association studies …

In the past 20 years, association studies of schizophrenia have evolved from analyses in
lesser than 100 subjects of one or two markers in candidate genes to systematic analyses of …

The spectacular advance in our understanding of the genetic basis of schizophrenia through
genome‐wide association studies has the potential to identify new leads for drug treatment …

Schizophrenia has a multifactorial etiology, involving a polygenic architecture. The potential
benefit of whole genome sequencing (WGS) in schizophrenia and other psychotic disorders …

Abstract Schizophrenia's (SZ's) heritability and familial transmission have been known for
several decades; however, despite the clear evidence for a genetic component, it has been …

Schizophrenia is a common, clinically heterogeneous disorder associated with lifelong
morbidity and early mortality. Several genetic variants associated with schizophrenia have …

Schizophrenia is a devastating neuropsychiatric disorder with genetically complex traits.
Genetic variants should explain a considerable portion of the risk for schizophrenia, and …

The new GWAS from the Schizophrenia Working Group of the Psychiatric Genomics
Consortium (2014) clearly validates a genetic approach to understanding schizophrenia …